Nitric oxide synthase 2 is involved in the pro-tumorigenic potential of γδ17 T cells in melanoma

OncoImmunology

Volumn 5, Issue 8, 2016, Pages

  Douguet, Laetitia ^a,b,c   Bod, Lloyd ^a,b,c   Lengagne, Renée ^a,b,c   Labarthe, Laura ^a,b,c,d   Kato, Masashi ^e   Avril, Marie Françoise ^a,b,c,f   Prévost Blondel, Armelle ^a,b,c  

^a INSERM   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f Institut Cochin   (France)

Author keywords

Interleukin 17; melanoma; NOS2; pro tumor functions; T cells

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 17; VASCULOTROPIN;

ADULT; AGED; ANIMAL CELL; ARTICLE; CARCINOGENIC ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS ASSAY; FEMALE; FLOW CYTOMETRY; GAMMA DELTA 17 T LYMPHOCYTE; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; LYMPHOCYTOTOXICITY; MALE; MELANOMA; METASTASIS; MICROSCOPY; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; ONCOGENE RET; POLYMORPHONUCLEAR CELL; PRIMARY TUMOR; PROTEIN EXPRESSION; SUPPRESSOR CELL; TUMOR CELL INOCULATION;

EID: 84983781350     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2016.1208878     Document Type: Article

References (37)

1. M.Girardi, D.E.Oppenheim, C.R.Steele, J.M.Lewis, E.Glusac, R.Filler, P.Hobby, B.Sutton, R.E.Tigelaar, A.C.Hayday. Regulation of cutaneous malignancy by gammadelta T cells. Science 2001; 294:605-9; PMID:11567106; http://dx.doi.org/10.1126/science.1063916
2. B.Silva-Santos, K.Serre, H.Norell. gammadelta T cells in cancer. Nat Rev Immunol 2015; 15:683-91; PMID:26449179; http://dx.doi.org/10.1038/nri3904
3. A.J.Gentles, A.M.Newman, C.L.Liu, S.V.Bratman, W.Feng, D.Kim, V.S.Nair, Y.Xu, A.Khuong, C.D.Hoang et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med 2015; 21:938-45; PMID:26193342; http://dx.doi.org/10.1038/nm.3909
4. T.Lanca, B.Silva-Santos. The split nature of tumor-infiltrating leukocytes:Implications for cancer surveillance and immunotherapy. Oncoimmunology 2012; 1:717-25; PMID:22934263; http://dx.doi.org/10.4161/onci.20068
5. Y.Ma, L.Aymeric, C.Locher, S.R.Mattarollo, N.F.Delahaye, P.Pereira, L.Boucontet, L.Apetoh, F.Ghiringhelli, N.Casares et al. Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy. J Exp Med 2011; 208:491-503; PMID:21383056; http://dx.doi.org/10.1084/jem.20100269
6. M.Cheng, L.Qian, G.Shen, G.Bian, T.Xu, W.Xu, S.Hu. Microbiota modulate tumoral immune surveillance in lung through a gammadeltaT17 immune cell-dependent mechanism. Cancer Res 2014; 74:4030-41; PMID:24947042; http://dx.doi.org/10.1158/0008-5472.CAN-13-2462
7. A.Takeuchi, T.Dejima, H.Yamada, K.Shibata, R.Nakamura, M.Eto, T.Nakatani, S.Naito, Y.Yoshikai. IL-17 production by gammadelta T cells is important for the antitumor effect of mycobacterium bovis bacillus Calmette-Guerin treatment against bladder cancer. Eur J Immunol 2011; 41:246-51; PMID:21182095; http://dx.doi.org/10.1002/eji.201040773
8. E.Lo Presti, F.Dieli, S.Meraviglia. Tumor-infiltrating gammadelta T lymphocytes:Pathogenic role, clinical significance, and differential programing in the tumor microenvironment. Front Immunol 2014; 5:607; PMID:25505472; http://dx.doi.org/10.3389/fimmu.2014.00607
9. M.Rei, D.J.Pennington, B.Silva-Santos. The Emerging Protumor Role of gammadelta T lymphocytes:Implications for cancer immunotherapy. Cancer Res 2015; 75(5):798-802; PMID:25660949; http://dx.doi.org/10.1158/0008-5472.CAN-14-3228
10. Y.Jianjun, R.Zhang, G.Lu, Y.Shen, L.Peng, C.Zhu, M.Cui, W.Wang, P.Arnaboldi, M.Tang et al. T cell-derived inducible nitric oxide synthase switches off Th17 cell differentiation. J Exp Med 2013; 210:1447-62; PMID:23797094; http://dx.doi.org/10.1084/jem.20122494
11. N.Obermajer, J.L.Wong, R.P.Edwards, K.Chen, M.Scott, S.Khader, J.K.Kolls, K.Odunsi, T.R.Billiar, P.Kalinski. Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling. J Exp Med 2013; 210:1433-445; PMID:23797095; http://dx.doi.org/10.1084/jem.20121277
12. J.Eyles, A.L.Puaux, X.Wang, B.Toh, C.Prakash, M.Hong, T.G.Tan, L.Zheng, L.C.Ong, Y.Jin et al. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J Clin Invest 2010; 120:2030-9; PMID:20501944; http://dx.doi.org/10.1172/JCI42002
13. M.Kato, M.Takahashi, A.A.Akhand, W.Liu, Y.Dai, S.Shimizu, T.Iwamoto, H.Suzuki, I.Nakashima. Transgenic mouse model for skin malignant melanoma. Oncogene 1998; 17:1885-8; PMID:9778055; http://dx.doi.org/10.1038/sj.onc.1202077
14. R.Lengagne, F.A.Le Gal, M.Garcette, L.Fiette, P.Ave, M.Kato, J.P.Briand, C.Massot, I.Nakashima, L.Renia et al. Spontaneous vitiligo in an animal model for human melanoma:role of tumor-specific CD8+ T cells. Cancer Res 2004; 64:1496-501; PMID:14973052; http://dx.doi.org/10.1158/0008-5472.CAN-03-2828
15. D.I.Gabrilovich, S.Ostrand-Rosenberg, V.Bronte. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012; 12:253-68; PMID:22437938; http://dx.doi.org/10.1038/nri3175
16. B.Toh, X.Wang, J.Keeble, W.J.Sim, K.Khoo, W.C.Wong, M.Kato, A.Prevost-Blondel, J.P.Thiery, J.P.Abastado. Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol 2011; 9:e1001162; PMID:21980263; http://dx.doi.org/10.1371/journal.pbio.1001162
17. S.B.Coffelt, K.Kersten, C.W.Doornebal, J.Weiden, K.Vrijland, C.S.Hau, N.J.Verstegen, M.Ciampricotti, L.J.Hawinkels, J.Jonkers et al. IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis. Nature 2015; 522:345-8; PMID:25822788; http://dx.doi.org/10.1038/nature14282
18. S.Ma, Q.Cheng, Y.Cai, H.Gong, Y.Wu, X.Yu, L.Shi, D.Wu, C.Dong, H.Liu. IL-17A produced by gammadelta T cells promotes tumor growth in hepatocellular carcinoma. Cancer Res 2014; 74:1969-82; PMID:24525743; http://dx.doi.org/10.1158/0008-5472.CAN-13-2534
19. P.Wu, D.Wu, C.Ni, J.Ye, W.Chen, G.Hu, Z.Wang, C.Wang, Z.Zhang, W.Xia et al. gammadeltaT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity 2014; 40:785-800; PMID:24816404; http://dx.doi.org/10.1016/j.immuni.2014.03.013
20. J.C.Ribot, A.deBarros, D.J.Pang, J.F.Neves, V.Peperzak, S.J.Roberts, M.Girardi, J.Borst, A.C.Hayday, D.J.Pennington et al. CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets. Nat Immunol 2009; 10:427-36; PMID:19270712; http://dx.doi.org/10.1038/ni.1717
21. S.Ekmekcioglu, J.Ellerhorst, C.M.Smid, V.G.Prieto, M.Munsell, A.C.Buzaid, E.A.Grimm. Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. Clin Cancer Res 2000; 6:4768-75; PMID:11156233
22. D.Massi, A.Franchi, I.Sardi, L.Magnelli, M.Paglierani, L.Borgognoni, U.Maria Reali, M.Santucci. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions. J Pathol 2001; 194:194-200; PMID:11400148; http://dx.doi.org/10.1002/1096-9896(200106)194:2%3c194::AID-PATH851%3e3.0.CO;2-S
23. C.C.Johansson, D.Mougiakakos, E.Trocme, C.All-Ericsson, M.A.Economou, O.Larsson, S.Seregard, R.Kiessling. Expression and prognostic significance of iNOS in uveal melanoma. Int J Cancer 2010; 126:2682-9; PMID:19847812; http://dx.doi.org/10.1002/ijc.24984
24. E.Dabbeche-Bouricha, L.M.Araujo, M.Kato, A.Prevost-Blondel, H.-J.Garchon. Rapid dissemination of RET-transgene driven melanoma in the presence of non-obese diabetic alleles:critical roles of Dectin-1 and Nitric-Oxide Synthase type 2. Oncoimmunology. 2015 Oct 29; 5(5):e1100793; PMID:27467912; http://dx.doi.org/10.1080/2162402X.2015.1100793
25. D.Wakita, K.Sumida, Y.Iwakura, H.Nishikawa, T.Ohkuri, K.Chamoto, H.Kitamura, T.Nishimura. Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis. Eur J Immunol 2010; 40:1927-37; PMID:20397212; http://dx.doi.org/10.1002/eji.200940157
26. S.R.Mattarollo, S.Loi, H.Duret, Y.Ma, L.Zitvogel, M.J.Smyth. Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors. Cancer Res 2011; 71:4809-20; PMID:21646474; http://dx.doi.org/10.1158/0008-5472.CAN-11-0753
27. Y.Gao, W.Yang, M.Pan, E.Scully, M.Girardi, L.H.Augenlicht, J.Craft, Z.Yin. Gamma delta T cells provide an early source of interferon gamma in tumor immunity. J Exp Med 2003; 198:433-42; PMID:12900519; http://dx.doi.org/10.1084/jem.20030584
28. W.He, J.Hao, S.Dong, Y.Gao, J.Tao, H.Chi, R.Flavell, R.L.O'Brien, W.K.Born, J.Craft et al. Naturally activated V gamma 4 gamma delta T cells play a protective role in tumor immunity through expression of eomesodermin. J Immunol 2010; 185:126-33; PMID:20525896; http://dx.doi.org/10.4049/jimmunol.0903767
29. T.Lanca, M.F.Costa, N.Goncalves-Sousa, M.Rei, A.R.Grosso, C.Penido, B.Silva-Santos. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic gammadelta T lymphocytes to tumor beds. J Immunol 2013; 190:6673-80; PMID:23686489; http://dx.doi.org/10.4049/jimmunol.1300434
30. Y.Carmi, G.Rinott, S.Dotan, M.Elkabets, P.Rider, E.Voronov, R.N.Apte. Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasis. J Immunol 2011; 186:3462-71; PMID:21300825; http://dx.doi.org/10.4049/jimmunol.1002901
31. J.Hao, S.Dong, S.Xia, W.He, H.Jia, S.Zhang, J.Wei, R.L.O'Brien, W.K.Born, Z.Wu et al. Regulatory role of Vgamma1 gammadelta T cells in tumor immunity through IL-4 production. J Immunol 2011; 187:4979-86; PMID:21987661; http://dx.doi.org/10.4049/jimmunol.1101389
32. C.Paget, M.T.Chow, H.Duret, S.R.Mattarollo, M.J.Smyth. Role of gammadelta T cells in alpha-galactosylceramide-mediated immunity. J Immunol 2012; 188:3928-39; PMID:22412194; http://dx.doi.org/10.4049/jimmunol.1103582
33. C.Bogdan. Nitric oxide and the immune response. Nat Immunol 2001; 2:907-16; PMID:11577346; http://dx.doi.org/10.1038/ni1001-907
34. N.Caccamo, C.La Mendola, V.Orlando, S.Meraviglia, M.Todaro, G.Stassi, G.Sireci, J.J.Fournie, F.Dieli. Differentiation, phenotype, and function of interleukin-17-producing human Vgamma9Vdelta2 T cells. Blood 2011; 118:129-38; PMID:21505189; http://dx.doi.org/10.1182/blood-2011-01-331298
35. C.Bogdan. Nitric oxide synthase in innate and adaptive immunity:an update. Trends Immunol 2015; 36(3):161-78; PMID:25687683; http://dx.doi.org/10.1016/j.it.2015.01.003
36. A.S.Saini, G.N.Shenoy, S.Rath, V.Bal, A.George. Inducible nitric oxide synthase is a major intermediate in signaling pathways for the survival of plasma cells. Nat Immunol 2014; 15:275-82; PMID:24441790; http://dx.doi.org/10.1038/ni.2806
37. R.Lengagne, A.Pommier, J.Caron, L.Douguet, M.Garcette, M.Kato, M.F.Avril, J.P.Abastado, N.Bercovici, B.Lucas et al. T cells contribute to tumor progression by favoring pro-tumoral properties of intra-tumoral myeloid cells in a mouse model for spontaneous melanoma. PLoS One 2011; 6:e20235; PMID:21633700; http://dx.doi.org/10.1371/journal.pone.0020235